Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
71.74
-0.35 (-0.49%)
Jan 2, 2025, 4:00 PM EST - Market closed
Hologic Revenue
In the fiscal year ending September 28, 2024, Hologic had annual revenue of $4.03B, down -0.00%. Hologic had revenue of $988.00M in the quarter ending September 28, 2024, with 4.52% growth.
Revenue (ttm)
$4.03B
Revenue Growth
-0.00%
P/S Ratio
4.22
Revenue / Employee
$576,581
Employees
6,990
Market Cap
16.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 28, 2024 | 4.03B | -100.00K | -0.00% |
| Sep 30, 2023 | 4.03B | -832.40M | -17.12% |
| Sep 24, 2022 | 4.86B | -769.50M | -13.66% |
| Sep 25, 2021 | 5.63B | 1.86B | 49.14% |
| Sep 26, 2020 | 3.78B | 409.10M | 12.15% |
| Sep 28, 2019 | Pro | Pro | Pro |
| Sep 29, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 24, 2016 | Pro | Pro | Pro |
| Sep 26, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 393.90B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.22B |
HOLX News
- 15 days ago - Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC - Business Wire
- 23 days ago - Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines - Business Wire
- 24 days ago - Martin Madaus Elected to Hologic Board of Directors - Business Wire
- 24 days ago - New Data To Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients With Minimal Risk of Distant Recurrence - Business Wire
- 4 weeks ago - Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations - Business Wire
- 5 weeks ago - Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024 - Business Wire
- 7 weeks ago - Hologic to Webcast Presentations at Upcoming Investor Conferences - Business Wire
- 2 months ago - Hologic, Inc. (HOLX) Q4 2024 Earnings Call Transcript - Seeking Alpha